Company Filing History:
Years Active: 2004-2007
Title: In Young Ko: Innovator in Monoclonal Antibody Research
Introduction
In Young Ko is a prominent inventor based in Anyang-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 6 patents to his name, his work has the potential to impact therapeutic approaches for various diseases.
Latest Patents
Ko's latest patents include groundbreaking inventions related to monoclonal antibodies. One of his notable patents is for an antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha. This invention includes a nucleic acid molecule encoding the same, a recombinant vector containing the nucleic acid molecule, and a cell transformed with the recombinant vector. Another significant patent focuses on the variable region of a monoclonal antibody against the HBV S-surface antigen, which also includes a gene encoding the same and a transformant obtained from the recombinant vector.
Career Highlights
In Young Ko is associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.
Collaborations
Ko has collaborated with notable colleagues in his field, including Moo Young Song and Jong Wook Lee. These collaborations have fostered a productive research environment, leading to significant advancements in monoclonal antibody technology.
Conclusion
In Young Ko's contributions to monoclonal antibody research exemplify the innovative spirit of modern biotechnology. His patents and collaborations continue to pave the way for advancements in medical treatments.